This is a preview of subscription content, access via your institution.
Notes
FTC v. Actavis, Inc., 133 S. Ct. 2223 (2013).
References
Carlson, J., Dafny, L. S., Freeborn, B. A., Ippolito, P. M., & Wendling, B. W. (2013). Economics at the FTC: Physician Acquisitions, Standard Essential Patents, and Accuracy of Credit Reporting. Review of Industrial Organization, 43, 303–326.
FTC Bureau of Economics (2010). Pay-for-delay: How drug company pay-offs cost consumer billions. http://www.ftc.gov/reports/pay-delay-how-drug-company-pay-offs-cost-customers-billions-federal-trade-commission-staff.
Kaplow, L. (2013). Competition policy and price fixing. Princeton: Princeton University Press.
Maskin, E., & Tirole, J. (1987). A theory of dynamic oligopoly, III: Cournot competition. European Economic Review, 31, 947–968.
Posner, R. (2001). Antitrust Law (2nd ed.). Chicago: University of Chicago Press.
Salinger, M., Ippolito, P., & Schrag, J. (2007). Economics at the FTC: Pharmaceutical Patent Dispute Settlements and Behavioral Economics. Review of Industrial Organization, 31, 85–105.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Farrell, J. The U.S. Federal Trade Commission at 100: A Symposium on FTC Economics. Rev Ind Organ 46, 1–3 (2015). https://doi.org/10.1007/s11151-014-9443-y
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11151-014-9443-y
Keywords
- Consumer Protection
- Equilibrium Path
- Horizontal Merger
- Merger Guideline
- Antitrust Division